A nationwide surveillance of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine in children with invasive pneumococcal disease (IPD)

At a glance
Trial Overview
Trial Details
Interventions
Results
- Publications
Authors
Trial History
References

Trial Profile

A nationwide surveillance of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine in children with invasive pneumococcal disease (IPD)

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 29 Apr 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
Indications Pneumococcal infections
Focus Therapeutic Use

Most Recent Events

23 Apr 2016 Results published in the Vaccine.
30 Dec 2015 New trial record

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com